The United States has delayed implementing a 100% tariff on Singapore’s patent pharmaceutical exports as stakeholders negotiate exemptions. Initially scheduled to take effect on 1 October, the tariff applies to patented and branded pharmaceutical exports, unless Singapore-based companies set up production facilities in the US.

Cross-border trade and cooperation still going strong in the booming medical device sector, according to senior figures across the industry.

The U.S. Drug Enforcement Administration has issued a temporary order placing seven benzimidazole-opioids in Schedule I of the Controlled Substances Act.

Special Provisions for Supervision and Administration of Traditional Chinese Medicine Production, released by the National Medical Products Administration on 8 September, apply to the production, supervision and administration of Chinese medicine decoction pieces and formula granules, proprietary Chinese medicine and herbal extracts. These new rules will enter into force on 1 March 2026.